osteogenic sarcoma

  • 成骨肉瘤;骨原性肉瘤
osteogenic sarcomaosteogenic sarcoma

noun

1
malignant bone tumor;most common in children and young adults where it tends to affect the femur
Synonym: osteosarcoma

数据来源:WordNet

  1. Li : My diagnosis is that you have a malignant tumor osteogenic sarcoma .

    李:我的诊断是您患了恶性骨原性肉瘤。

  2. Clinical Pathological Analyse of Osteogenic Sarcoma of Bone SurFace on 30 Cases

    30例骨表面骨肉瘤临床病理分析

  3. Objective To study the effect of tretinoin on cellular proliferation and differentiation with human osteogenic sarcoma cell .

    目的探讨维甲酸对人骨肉瘤细胞抑制增殖和诱导分化的影响。

  4. Objective To investigate early clinical manifestations of osteogenic sarcoma to help establishment of an early diagnosis of the disease .

    目的试图找出成骨肉瘤早期临床表现的特点和规律,为其早期诊断提供帮助。

  5. Induced-differentiation effects of cinnamic acid on human osteogenic sarcoma cells cultured primarily in vitro

    人骨肉瘤细胞体外培养与桂皮酸诱导分化的实验研究肉桂,牧桂生桂皮的树木

  6. High Dose Chemotherapy for Osteogenic Sarcoma

    骨肉瘤的大剂量化疗

  7. Non - Amputation for the Treatment of Osteogenic Sarcoma

    不截肢治疗骨肉瘤

  8. The conventional treatment of osteogenic sarcoma is a high amputation as well as disarticulation .

    骨肉瘤的传统疗法是高位截肢,关节离断。

  9. A Study on Immunohistochemical Localization of Anti-human Osteosarcoma Monoclonal Antibodies in Osteogenic Sarcoma Tissues

    抗骨肉瘤单克隆抗体在骨肉瘤组织中的免疫组化定位研究

  10. Non-Amputation for the Treatment of Osteogenic Sarcoma A case of leg liposarcoma

    不截肢治疗骨肉瘤小腿脂肪肉瘤1例

  11. Comparison of antitumor activity between TIL and LAK cells of human osteogenic sarcoma and phenotypic analysis of TIL

    人骨肉瘤浸润淋巴细胞和LAK细胞体外抗瘤作用比较及表型分析

  12. Inhibitory effects of hexamethylene bisacetamide combined with taxol on human osteogenic sarcoma cell line OS-9901

    六亚甲基双乙酰胺与紫杉醇合用对人骨肉瘤OS-9901细胞的抑制作用

  13. Effect of Fullerenes ( C_ ( 60 )) - glycin Derivatives on the Mouse Osteogenic Sarcoma Cells Growth

    富勒烯(C(60))-甘氨酸衍生物对小鼠骨肉瘤细胞生长的影响

  14. It is suggested that the diagnostic term & osteogenic sarcoma of the bone surface should be used and marked with tumors ' differentiated classification .

    建议诊断时使用骨表面骨肉瘤名称,同时标明肿瘤分化级别。

  15. The patients with the local mass had a delayed diagnosis of osteogenic sarcoma with a delayed duration of 1-14 weeks , averaged 4 weeks ;

    首诊有局部包块者,医生拖延诊断时间1~14周,平均4周;

  16. The toxic effect of new conjugate on human osteoblast is light . Moreover , the new conjugate has strong induction of MG-63 osteogenic sarcoma cell apoptosis .

    偶联物对人成骨细胞的毒性作用轻微;偶联物对骨肉瘤MG-63细胞有较强的诱导凋亡作用,随着偶联物浓度的升高及作用时间的延长MG-63细胞的凋亡率逐渐上升。

  17. The acridine orange dye tests implied that : with the increasing of drug concentration and the prolongation of time , the osteogenic sarcoma cell was decreased in volume .

    丫啶橙染色结果:随着药物浓度提高和作用时间延长,可见凋亡小体形成。

  18. CONCLUSION : In the simulated in vivo environment , CPC has slow and sustained release effect on anticancer drug Cisplatin and medium inhibitory effect on osteogenic sarcoma cell OS-9607 .

    结论:在模拟体内环境下,磷酸钙骨水泥对抗肿瘤药物顺铂有缓慢而持久的体外释放作用,且对骨肉瘤细胞OS-9607具有中等抑制效果。

  19. Establishing recombinant secretory anti-osteoblastic sarcoma single-chain bifunctional antibody gene ; This is an osteosarcoma ( a variant known as parosteal osteogenic sarcoma ) of bone .

    分泌型抗成骨肉瘤单链双功能抗体融合基因表达载体的构建这是一个骨肉瘤的病例(为骨旁骨肉瘤亚型)。

  20. RESULTS : ① Two days after ATRA treatment , average inhibitory rate of human osteogenic sarcoma cell line OS-9901 was 25.2 % , 51.7 % on the fourth day , and 68.4 % on the sixth day .

    结果:①全反式维甲酸处理第2天对人骨肉瘤OS-9901细胞生长的平均抑制率为25.2%,第4天达到51.7%,第6天为68.4%。

  21. Objective : The purpose of this paper was to study the effect of recombinant human gamma interferon ( rhIFN - γ) on glucocorticoid receptor ( GR ) expression in HOS-8603 . cells , a human osteogenic sarcoma cell line .

    以人骨肉瘤细胞系(HOS-8603)为模型,研究重组人γ干扰素(rhIFN-γ)对糖皮质激素受体(GR)的调节作用及其生物学意义。

  22. Objective : To prepare decalcified bone matrix particles ( DBMP ) with adriamycin impregnated bone cement ( BC ) drug sustained delivery system ( DSDS ), it drug delivery characteristic and inhibitory ability on human osteogenic sarcoma cell OS-9901 were analysed .

    目的:研制阿霉素异体脱钙骨基质骨粒骨水泥缓释体,分析其缓释性能及对骨肉瘤细胞OS-9901的抑制能力。

  23. By using monoclonal antibodies against CacyBP / SIP firstly produced in our laboratory , we found that CacyBP / SIP was detected almost in all kinds of tumor tissues and was highly expressed in pancreatic cancer , nasopharyngeal carcinoma , and osteogenic sarcoma .

    应用我们实验室率先制备的CacyBP/SIP单克隆抗体,我们发现CacyBP/SIP在大部分的肿瘤组织中表达,在胰腺癌,鼻咽癌和骨肉瘤中高表达。

  24. Osteogenic Potential of Human Traumatologic and Osteoarthritic Synoviocytes Cultured in vitro Preparation of monoclonal antibodies against human osteogenic sarcoma and its characteristics

    损伤性和骨关节炎性滑膜细胞成骨作用的体外研究抗人成骨肉瘤单克隆抗体的制备及其特性